If any of us knew how much and when it would be one of two things, clairvoyant or insider trading. Nearly unchanged on an ugly day in the streets is starting to sound like a positive:))
How about: agree that the oig investigation is basically non material at this point and could take years to resolve. As to the FDA, as I have said previously with the change of leadership in Washington I feel there should be resolutions forthcoming, however I would find it hard to believe if it was made public. As Pete has stated, he just wants it to stop...
Pacora: I think many if the large investors are in mdxg because of Pete and all are assuming that he will come through like he always has. In terms of Metronic, I think it is much more meaningful for mdxg than it is for Medtronic as adding mdxg to their products might enhance their applications but not add anything meaningful to their bottom line. With that said, we are over 1.5 years into the relationship, I know their sales team has gone through training and I also hear there are other applications they are interested in.
Volstate, you. Missed my point, the CEO just stated " we have 10 billion that we are going to invest". I wasn't trying to surmise anything, just stating his comments.
CEO of Medtronic on cnbc after completing their inversion just said they now have 10 billion available for investments in the us markets in early stage technologies ?????.
I listened to the replay, Pete made a comment in the beginning that they have isolated the source and they will be dealing with it next week to stop it. Bill gave normal presentation, spent some time describing these new contracts and how that should reassure anyone worried about cms bundling issues...Senken spoke usual CFO stuff and mentioned the sales practices and everything is in order. All in all sounded much like the last 20 presentations however q and a was in a closed room and not for the taped presentation.
As bad of a two week trend as we have had, even I will say this looks horrible not having the presentation work, very embarrassing , I expect the stock to be spanked and Pete's phone to be raining off of the hook. You younger traders may not understand what a phone hook used to be:))
Yappy,you are officially an idiot to say mdxg is going down on slow rev growth and no earnings, really?? You either don't know how to read, or don't care to speak the truth, for that, you are an idiot. I am a large mdxg holder and own a bit of OSIR, looking like it is trying to break above 17.
Hostile takeover, where on earth did that come from:)). Some of you nervous nellies crack me up, the hard part in this stock was buying in at 1ish and watching the stock not move for 3 years on low volume. Now we are up 900 percent on over a million shares traded per day. Go play in play in fixed income if you can't handle swings. Mdxg will get bought out in 2015 above 20 and Dow jones will break 20,000 in 2015, as Arron Rogers said, RELAX!!!
Mdxg down 25 % YTD. One comment, in most of the down drafts we have experienced over the past few years, except for the exception of a news driven drop, volume has for the most part been low. Yesterday was a high volume sell off. Volume has been rapidly increasing over the past month and my main point is this is a new trend. Looks like technically we need to hold the 8.50 area or we are heading down to the 7 support area. Mdxg is presenting on Thursday at the JP Morgan Healthcare conference. I hear rumors of new test results and indications, would be nice to see something to support the stock soon. Medtronic buyout cannot come soon enough:))
Larrydett, I see you have been on these boards for 15 years, so I will just assume you are lazy not looking up earnings for mdxg, company did 118 million last year, 90 percent gross margins and will earn near 6 cents per share and next year is expected to do 200 million in sales and has forecasted 15% profits to the bottom line or 30million, company at the end of this year has 50 million cash in the bank with zero debt. Has some FDA hurdles to clear with game changing disruptive product in the tendon pain management business ....listen to the last conference call for mdxg and you can get your facts straight on the current issues.
We know there are questions if the FDA was persuaded by outside influence to mdxg, we have also said that Pete Petit is close with republican US Senator From Georgia Johnny Isakson. Here is a quote from a few years ago regarding Pete's insider trading case (which was dismissed) but nonetheless it shows their relationship and we have it from a good source Mr. Isakson will be protecting the interest of his Georgia company mdxg
This is what Johnny Isakson was quoted in an Atlanta Newspaper regarding his friend Pete Petit:
“I’ve known him for going on 45 years and I’ve never known a finer guy,” U.S. Sen. Johnny Isakson said. “I’m confident he will be exonerated.”
And yes Johnny was correct, Pete was 100 percent exonerated much to the dismay of the shorts.
Here is a copy if a letter that was just sent to me:
Greetings ARM Members,
Geoff MacKay, president and CEO of Organogenesis Inc., announced that following 11 years in his current position, he has resigned from his company, effective December 2014.
He is also stepping down from his role as chairman of the Alliance for Regenerative Medicine. His two-year term is scheduled to conclude on December 31, 2014.
In his role as ARM chairman, Geoff MacKay played a key role in overseeing and advancing the Alliance’s mission and growth, securing record membership levels, the creation of new technology sections and the creation of ARM’s European Section following the merger with the Alliance for Advanced Therapies. ARM thanks Geoff for his leadership and dedicated efforts and wishes him well in his future endeavors.
On November 10, 2014, ARM announced the election of Edward Lanphier, founder, president and CEO of Sangamo BioSciences, as its incoming chairman. As one of the industry’s most experienced and respected CEOs, Edward is well positioned to lead ARM into 2015, continuing its growth momentum and further accelerating progress of regenerative medicine and advanced therapies.
Director of Membership and Advocacy
Alliance for Regenerative Medicine
Both Pete and Bill have confirmed this in last conference call. Only physical reference I have seen is on,this is the organogenesis ceo's linkedin profile shows a change, but being sa privately held company they aren't required to give details, and the fact they haven't put out a pr saying the bs line of pursuing personal interests that they know the #$%$ has hit the fan and you can figure out the rest. This would make a good storyline on House of cards.
PAC you are correct, we can look forward to pr Monday, will they beat the raised beat:)). They present on the 15th
Then please don't post that garbage because 1/2 of it are lies and it just confuses people, again, this was spoken about 3 days ago in many posts. I am by no means the board police, but even I dislike lies and this whole Organogensis and FDA #$%$ has me upset, I really dislike falsehoods, cheats and evilness and I have about 5 million reasons why I want the truth in mdxg to be focused on.